Sign In
Buy SEEL
$0.400
+0 (+0%)
At Close: Feb 14, 2025
Midday Market Update: What Stocks Are Up Today?
12:32pm, Friday, 12'th Mar 2021
The stock market has some major movers as noon rolls around on Friday and InvestorPlace is looking at what stocks are up today. The post Midday Market Update: What Stocks Are Up Today?
Why Seelos Therapeutics Stock Is Skyrocketing Today
11:44am, Friday, 12'th Mar 2021
An analyst is really bullish about the biotech stock.
SEEL Stock Price Increases Over 40% Pre-Market: Why It Happened
07:26am, Friday, 12'th Mar 2021
The stock price of Seelos Therapeutics Inc (NASDAQ: SEEL) is trading at over 40% pre-market. This is why it happened.
Seelos Therapeutics: SLS-002 For Suicidality Is Very Promising
12:38pm, Thursday, 11'th Mar 2021
SLS-002 alone warrants an upside of at least 3x times in the event of full FDA approval. Market participants are underestimating the clinical trial success probabilities of SLS-002.
Seelos Therapeutics Buys Back Portion Of SLS002-Related Royalties
08:38am, Thursday, 18'th Feb 2021
Seelos Therapeutics Inc (NASDAQ: SEEL) has amended the agreement with Vyera Pharmaceuticals AG, announced in March 2018, to develop SLS-002 to repurchase a significant portion of the royalties pa
NEW YORK, Jan. 28, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorder
Why Novartis, Seelos Therapeutics And More Are Moving Today
11:52am, Tuesday, 26'th Jan 2021
Allogene Therapeutics (NASDAQ: ALLO) shares are trading higher Tuesday after Stifel upgraded the stock from Hold to Buy and raised its price target from $33 to $43 per share. Allogene is a U.S.-based
Why Fluidigm, Seelos Therapeutics And More Are Moving Today
11:27am, Friday, 22'nd Jan 2021
Fluidigm (NASDAQ: FLDM) shares are trading higher Friday after the company announced it received the CE-IVD mark for its Advanta Dx SARS-CoV-2 RT-PCR Assay. Fluidigm manufactures life science tools fo
NEW YORK, Jan. 15, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorder
Seelos Therapeutics to Participate in the 3rd International Conference on Sanfilippo Syndrome and Related Diseases
09:24am, Monday, 09'th Nov 2020
NEW YORK, Nov. 9, 2020 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders
